NORDEA INVESTMENT MANAGEMENT AB
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1218210
STOCKHOLM, V7
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$72,876,949
-$33,117,009 QoQ
Shares Held
94,322
-31.3% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.1070800025444753.ToString("F0")%
Shared 0.ToString("F0")%
None 99.89291999745552.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORDEA INVESTMENT MANAGEMENT AB holds $224,709,274 across 23 Biotechnology names. REGN ranks #1 (32.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
94,322 | $72,876,949 | |
| 2 | RPRX |
Royalty Pharma plc
|
788,022 | $37,801,414 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
306,439 | $19,213,724 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,171 | $12,132,937 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
50,936 | $10,169,371 | |
| 6 | EXEL |
Exelixis, Inc.
|
201,553 | $8,644,607 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
113,902 | $6,434,323 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
51,821 | $5,461,932 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $72,876,949 | 94,322 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $105,993,958 | 137,321 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $35,406,703 | 62,971 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $24,668,700 | 46,988 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $28,045,649 | 44,220 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $30,392,982 | 42,667 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $36,301,418 | 34,532 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $47,570,668 | 45,261 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $28,099,895 | 29,195 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $20,815,473 | 23,700 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $19,575,749 | 23,787 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $18,071,999 | 25,151 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $21,010,101 | 25,570 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $18,196,699 | 25,221 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $18,038,060 | 26,185 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $19,140,198 | 32,379 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $34,131,785 | 48,870 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $32,255,515 | 51,076 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $31,495,382 | 52,043 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $28,403,434 | 50,853 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $23,838,685 | 50,384 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $23,244,354 | 48,114 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $24,373,380 | 43,541 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $27,381,976 | 43,906 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,613,905 | 15,593 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||